You can use the form below to sign up for email alerts about new positions as they open. Fields marked with an asterisk (*) are required. Genomics England partners with the NHS to provide whole genome ...
You can use the form below to sign up for email alerts about new positions as they open. Fields marked with an asterisk (*) are required. Genomics England partners with the NHS to provide whole genome ...
You can use the form below to sign up for email alerts about new positions as they open. Fields marked with an asterisk (*) are required. Genomics England partners with the NHS to provide whole genome ...
Hundreds of babies have begun to be tested for over 200 rare genetic conditions as part of a world-leading study in NHS hospitals that aims to screen up to 100,000 newborns in England. The Generation ...
Study shows that combining whole genome sequence and clinical data together at scale supports the delivery of precision cancer care, where cancer diagnosis and treatment is tailored to the individual ...
Genomics England’s Generation Study has now enrolled 25,000 babies - a major milestone in one of the world’s largest research studies of its kind to explore how whole genome sequencing could be used ...
In this episode of our explainer podcasts, we’ve asked Emma McCargow, Programme Lead for the cancer programme at Genomics England, to explain in less than 10 minutes, the difference between long-read ...
In this series, ‘Genomics 101’, we go back to basics and explore some of the most important topics in genomics. In this blog, we explain what is meant by RNA, how it is different from DNA, and why our ...
Will provide definitive diagnoses for more patients and uncover novel mechanisms of disease Consensus-based recommendations expand upon existing standards developed for gene panel and exome testing, ...
Genomics England sets out early thinking on how a research pilot will gather evidence on the benefits, challenges and practicalities of offering whole genome sequencing to all newborns Research will ...
We're going back to basics today, and in this explainer podcast, we’ve asked Greg Elgar, Director of Sequencing R&D here at Genomics England, to clarify in less than 10 minutes, exactly what is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results